TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice (2018)
Source: International Journal of Molecular Sciences. Unidades: FMVZ, FCF
Subjects: HEPATOPATIAS, CONEXINAS, FIBROSE CÍSTICA
ABNT
YANGUAS, Sara Crespo et al. TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice. International Journal of Molecular Sciences, v. 19, n. 3, p. 1-17, 2018Tradução . . Disponível em: https://doi.org/10.3390/ijms19030817. Acesso em: 01 nov. 2024.APA
Yanguas, S. C., Silva, T. C. da, Pereira, I. V. A., Willebrords, J., Maes, M., Nogueira, M. S., et al. (2018). TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice. International Journal of Molecular Sciences, 19( 3), 1-17. doi:10.3390/ijms19030817NLM
Yanguas SC, Silva TC da, Pereira IVA, Willebrords J, Maes M, Nogueira MS, Castro IA de, Leclercq I, Romualdo GR, Barbisan LF, Leybaert L, Cogliati B, Vinken M. TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice [Internet]. International Journal of Molecular Sciences. 2018 ; 19( 3): 1-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/ijms19030817Vancouver
Yanguas SC, Silva TC da, Pereira IVA, Willebrords J, Maes M, Nogueira MS, Castro IA de, Leclercq I, Romualdo GR, Barbisan LF, Leybaert L, Cogliati B, Vinken M. TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice [Internet]. International Journal of Molecular Sciences. 2018 ; 19( 3): 1-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/ijms19030817